Latest filing published 07 May 2019 for Alliqua BioMedical, Inc..
Eckard Weber is a declared insider at 3 companies; the most frequent names are Ocera Therapeutics, Inc., Alliqua BioMedical, Inc. and Tobira Therapeutics, Inc. We count 8 filings; the first trade dates from 4 January 2016 and the latest from 3 May 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 7 May 2019: a share grant, in Alliqua BioMedical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations